Projects
Transcriptome sequencing-based comparison of Myeloproliferative Neoplasms, with and without driver mutations, to identify molecular targets in triple-negative MPNs for precision therapy development
Project Description
Transcriptome sequencing-based comparison of Myeloproliferative Neoplasms, with and without driver mutations, to identify molecular targets in triple-negative MPNs for precision therapy development
Project Duration
2023 - 2026
Project Lead
Dr Sweta Srivastava
Authors
Dr Sweta S, Dr Cecil Ross, Dr Seetharam, Dr Hari
Project Status
ongoing
Project Type
PI